Table 2.
OGTT Data of the Subjects Whose Genetic Analyses Were Performed, Excluding Case 5 and Case 11
Characteristic |
Time, min |
Glycemic Status | ||||||
---|---|---|---|---|---|---|---|---|
0 | 30 | 60 | 120 | 180 | 240 | 300 | ||
Case 1 | Diabetes | |||||||
Glucose (mg/dL) | 103 | 222 | 270 | 236 | 135 | 87 | 46a | |
IRI (µU/mL) | 17.7 | 62.4 | 108.2 | 210.8b | 133.7 | 79.1 | 7.7 | |
Case 2 | IGT | |||||||
Glucose (mg/dL) | 114 | 174 | 184 | 163 | 73a | 77 | 90 | |
IRI (µU/mL) | 27.5 | 118 | 178.3 | 178.4b | 25.5 | 10.1 | 10.5 | |
Case 3 | NGT | |||||||
Glucose (mg/dL) | 91a | 154 | 134 | 114 | 93 | |||
IRI (µU/mL) | 9.1 | 158.7 | 232.8b | 42.5 | 35.7 | |||
Case 4 | IGT | |||||||
Glucose (mg/dL) | 96 | 121 | 178 | 150 | 127 | 50a | 80 | |
IRI (µU/mL) | 15.9 | 68.3 | 111.6 | 113.3b | 108.5 | 14.5 | 8.1 | |
Case 6 | NGT | |||||||
Glucose (mg/dL) | 96 | 214 | 188 | 83 | 72a | 81 | 84 | |
IRI (µU/mL) | 24.1 | 423.0b | 387.0 | 110.3 | 22.5 | 13.1 | 24.0 | |
Case 7 | IGT | |||||||
Glucose (mg/dL) | 108 | 214 | 243 | 182 | 92 | 62a | 81 | |
IRI (µU/mL) | 30.3 | 207.5 | 269.8 | 279.1b | 101.3 | 32.4 | 20.9 | |
Case 8 | IGT | |||||||
Glucose (mg/dL) | 96 | 171 | 193 | 176 | 92 | 52a | 75 | |
IRI (µU/mL) | 11.0 | 68.9 | 86.5 | 196.5b | 71.9 | 9.5 | 9.1 | |
Case 9 | IGT | |||||||
Glucose (mg/dL) | 87a | 152 | 130 | 148 | 121 | |||
IRI (µU/mL) | 8.8 | 79.0b | 55.4 | 72.8 | 53.1 | |||
Case 10 | NGT | |||||||
Glucose (mg/dL) | 100 | 164 | 159 | 113 | 75a | 88 | 91 | |
IRI (µU/mL) | 19.7 | 180.9 | 198.9b | 142.7 | 28.7 | 15.7 | 17.8 |
Abbreviations: IGT, impaired glucose tolerance; IRI, immunoreactive insulin; NGT, normal glucose tolerance.
Minimum glucose level.
Peak immunoreactive insulin level.